Lv3
400 积分 2024-12-12 加入
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
2天前
已完结
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
1个月前
已完结
Understanding the impact of psychosocial working conditions on workers’ health: we have come a long way, but are we there yet?
2个月前
已完结
HER3: Updates and current biology function, targeted therapy and pathologic detecting methods
4个月前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
4个月前
已完结
VEGF targets the tumour cell
4个月前
已完结
Anti-angiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors
4个月前
已完结
Revisiting VEGF/VEGFR-2 signalling as an anticancer target and its inhibitor discovery: where are we and where should we go?
4个月前
已完结
VEGFR‐2 expression in carcinoid cancer cells and its role in tumor growth and metastasis
4个月前
已完结
HER3: Updates and current biology function, targeted therapy and pathologic detecting methods
5个月前
已完结
皖公网安备34019202002308
